Joel Greenblatt's position in Abbott Laboratories is currently worth $3.25 Million. That's 0.06% of their equity portfolio (420th largest holding). The first Abbott Laboratories trade was made in Q4 2010. Since then Joel Greenblatt bought shares twenty more times and sold shares on 25 occasions. The stake costed the investor $1.96 Million, netting the investor a gain of 66% so far.